DK0620731T3 - Farmaceutisk præparat i form af en bruse- og/eller henfaldstablet eller et instantgranulat samt fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutisk præparat i form af en bruse- og/eller henfaldstablet eller et instantgranulat samt fremgangsmåde til fremstilling derafInfo
- Publication number
- DK0620731T3 DK0620731T3 DK93902180.4T DK93902180T DK0620731T3 DK 0620731 T3 DK0620731 T3 DK 0620731T3 DK 93902180 T DK93902180 T DK 93902180T DK 0620731 T3 DK0620731 T3 DK 0620731T3
- Authority
- DK
- Denmark
- Prior art keywords
- active ingredient
- pct
- matrix
- amount
- tablet
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 7
- 239000011159 matrix material Substances 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- -1 alkaline earth metal salts Chemical class 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 150000001805 chlorine compounds Chemical class 0.000 abstract 1
- 230000001934 delay Effects 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 150000002194 fatty esters Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000011872 intimate mixture Substances 0.000 abstract 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960001571 loperamide Drugs 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 229920000193 polymethacrylate Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92100441 | 1992-01-13 | ||
PCT/EP1993/000055 WO1993013760A1 (de) | 1992-01-13 | 1993-01-12 | Pharmazeutische zubereitung in form einer brause- und/oder zerfallstablette oder eines instantgranulats, sowie verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0620731T3 true DK0620731T3 (da) | 1996-04-09 |
Family
ID=8209237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93902180.4T DK0620731T3 (da) | 1992-01-13 | 1993-01-12 | Farmaceutisk præparat i form af en bruse- og/eller henfaldstablet eller et instantgranulat samt fremgangsmåde til fremstilling deraf |
Country Status (16)
Country | Link |
---|---|
US (1) | US5587179A (cs) |
EP (1) | EP0620731B1 (cs) |
JP (1) | JPH07506336A (cs) |
AT (1) | ATE128028T1 (cs) |
AU (1) | AU668375B2 (cs) |
CA (1) | CA2127352C (cs) |
CZ (1) | CZ283351B6 (cs) |
DE (1) | DE59300632D1 (cs) |
DK (1) | DK0620731T3 (cs) |
ES (1) | ES2068800T3 (cs) |
FI (1) | FI110353B (cs) |
GR (2) | GR950300005T1 (cs) |
MX (1) | MX9300110A (cs) |
PL (1) | PL173676B1 (cs) |
WO (1) | WO1993013760A1 (cs) |
ZA (1) | ZA93215B (cs) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5395627A (en) * | 1992-09-04 | 1995-03-07 | Akzo N.V. | Pharmaceutical granulate |
DE4403943A1 (de) * | 1994-02-08 | 1995-08-10 | Hexal Pharma Gmbh | Orale Azrneimittelzubereitung mit Diclofenac-Natrium |
TW466119B (en) * | 1994-02-28 | 2001-12-01 | Janssen Pharmaceutica Nv | Film coated tablet of paracetamol and domperidone |
US5837287A (en) * | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
GB9421836D0 (en) * | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
US5807577A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
GB9710767D0 (en) * | 1996-06-26 | 1997-07-23 | On Ninh | Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same |
BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
US5843477A (en) * | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
DE19814257A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
DE19822036A1 (de) * | 1998-05-15 | 1999-11-18 | Bayer Ag | Brausezubereitungen |
GB9816899D0 (en) | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
US7001612B2 (en) | 1998-08-26 | 2006-02-21 | All Sun Hsf Company Limited | Composition for the relief of heat stress |
US6235322B1 (en) * | 1999-03-09 | 2001-05-22 | Mintech, Inc. | Highly soluble and stable mineral supplements containing calcium and magnesium |
US6284270B1 (en) | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
AU5060499A (en) * | 1999-08-04 | 2001-03-05 | Ranbaxy Laboratories Limited | Hydrodynamically balanced oral drug delivery system |
PL204106B1 (pl) * | 2000-02-28 | 2009-12-31 | Pharmakodex Ltd | Zestaw do dostarczania środka terapeutycznego |
AU2001275043A1 (en) | 2000-05-31 | 2001-12-11 | Drugtech Corporation | Mineral supplement |
GB0222612D0 (en) * | 2002-09-30 | 2002-11-06 | Univ Gent | Controlled delivery system for bioactive substances |
JP2006506362A (ja) * | 2002-10-11 | 2006-02-23 | デポメド・ディベロップメント・リミテッド | 胃内保持型レボドパデリバリー形態 |
JP4601271B2 (ja) * | 2003-08-01 | 2010-12-22 | 大洋薬品工業株式会社 | 圧縮成形製剤およびその製造方法 |
WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
US7491263B2 (en) | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
EP1954298A4 (en) | 2005-11-28 | 2012-10-31 | Imaginot Pty Ltd | DISPENSING SYSTEM FOR ORAL THERAPEUTIC CONNECTION |
EP1902708A1 (de) | 2006-09-25 | 2008-03-26 | Losan Pharma GmbH | Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung |
CN101084881B (zh) * | 2007-06-23 | 2012-08-29 | 淮北辉克药业有限公司 | 靶向速释泡腾制剂及其制备方法 |
EP2217213B1 (en) | 2007-10-31 | 2017-05-24 | Johnson & Johnson Consumer Inc. | Orally disintegrative dosage form |
US20110318411A1 (en) | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
US8313768B2 (en) | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
US9610224B2 (en) | 2009-09-24 | 2017-04-04 | Johnson & Johnson Consumer Inc. | Manufacture of tablet in a die utilizing powder blend containing water-containing material |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
ES2763945T3 (es) | 2013-02-06 | 2020-06-01 | Hermes Arzneimittel Gmbh | Composiciones farmacéuticas que incorporan fármacos en dosis bajas |
KR20160107254A (ko) | 2014-01-10 | 2016-09-13 | 존슨 앤드 존슨 컨수머 인코포레이티드 | 고주파 및 손실 코팅된 입자를 사용하여 정제를 제조하는 방법 |
DK3157506T3 (da) | 2014-06-20 | 2020-11-23 | Hermes Arzneimittel Gmbh | Smagsmaskeret oral, farmaceutisk sammensætning |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4289751A (en) * | 1979-06-29 | 1981-09-15 | Merck & Co., Inc. | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
US4539198A (en) * | 1983-07-07 | 1985-09-03 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
DE3440288C2 (de) * | 1984-11-05 | 1987-03-12 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung |
DE3524003A1 (de) * | 1985-07-04 | 1987-01-08 | Heumann Ludwig & Co Gmbh | Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung |
JPH0830005B2 (ja) * | 1985-09-25 | 1996-03-27 | ゲルゲリイ、ゲルハルト | 崩壊性錠剤とその製造方法 |
US4753800A (en) * | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
NZ231281A (en) * | 1988-11-08 | 1991-01-29 | Takeda Chemical Industries Ltd | Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol |
GB8908361D0 (en) * | 1989-04-13 | 1989-06-01 | Beecham Group Plc | Composition |
-
1993
- 1993-01-11 MX MX9300110A patent/MX9300110A/es not_active IP Right Cessation
- 1993-01-12 JP JP5512137A patent/JPH07506336A/ja active Pending
- 1993-01-12 DE DE59300632T patent/DE59300632D1/de not_active Expired - Lifetime
- 1993-01-12 ES ES93902180T patent/ES2068800T3/es not_active Expired - Lifetime
- 1993-01-12 CZ CZ941605A patent/CZ283351B6/cs not_active IP Right Cessation
- 1993-01-12 DK DK93902180.4T patent/DK0620731T3/da active
- 1993-01-12 CA CA002127352A patent/CA2127352C/en not_active Expired - Fee Related
- 1993-01-12 AU AU33492/93A patent/AU668375B2/en not_active Ceased
- 1993-01-12 AT AT93902180T patent/ATE128028T1/de active
- 1993-01-12 US US08/256,503 patent/US5587179A/en not_active Expired - Lifetime
- 1993-01-12 WO PCT/EP1993/000055 patent/WO1993013760A1/de active IP Right Grant
- 1993-01-12 PL PL93304677A patent/PL173676B1/pl not_active IP Right Cessation
- 1993-01-12 EP EP93902180A patent/EP0620731B1/de not_active Expired - Lifetime
- 1993-01-13 ZA ZA93215A patent/ZA93215B/xx unknown
-
1994
- 1994-07-12 FI FI943315A patent/FI110353B/fi active
-
1995
- 1995-02-28 GR GR950300005T patent/GR950300005T1/el unknown
- 1995-10-18 GR GR950402909T patent/GR3017806T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE59300632D1 (de) | 1995-10-26 |
FI110353B (fi) | 2002-12-31 |
GR950300005T1 (en) | 1995-02-28 |
FI943315A7 (fi) | 1994-07-12 |
AU3349293A (en) | 1993-08-03 |
EP0620731B1 (de) | 1995-09-20 |
GR3017806T3 (en) | 1996-01-31 |
CA2127352C (en) | 2005-05-31 |
EP0620731A1 (de) | 1994-10-26 |
WO1993013760A1 (de) | 1993-07-22 |
AU668375B2 (en) | 1996-05-02 |
ES2068800T1 (es) | 1995-05-01 |
ES2068800T3 (es) | 1995-12-16 |
JPH07506336A (ja) | 1995-07-13 |
CZ283351B6 (cs) | 1998-03-18 |
PL173676B1 (pl) | 1998-04-30 |
FI943315A0 (fi) | 1994-07-12 |
US5587179A (en) | 1996-12-24 |
MX9300110A (es) | 1994-07-29 |
CZ160594A3 (en) | 1994-12-15 |
CA2127352A1 (en) | 1993-07-22 |
ZA93215B (en) | 1993-08-19 |
ATE128028T1 (de) | 1995-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0620731T3 (da) | Farmaceutisk præparat i form af en bruse- og/eller henfaldstablet eller et instantgranulat samt fremgangsmåde til fremstilling deraf | |
IL111647A0 (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them | |
FI820467L (fi) | Farmaceutiska kompositioner som frigoers kontinuerligt | |
UA26455C2 (uk) | Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта | |
GR3031135T3 (en) | Compositions containing S(+)-Ibuprofen. | |
ES2058111T3 (es) | Composicion de liberacion controlada de dihidrocodeina. | |
DE3773468D1 (de) | Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung. | |
ES2110212T3 (es) | Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion. | |
BR9916361A (pt) | Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia | |
ATE220321T1 (de) | Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe | |
KR970702291A (ko) | 에퀼린의 산 이성질화체로부터 제조된 에퀼린 이중결합 이성질체(Anequilin double bond isomer from the acid isomerization of equilin) | |
IS1834B (is) | Lyfjablöndur til inntöku um munn með breytta losun sem innihalda 5-ASA. | |
ES2172179T3 (es) | Composiciones farmaceuticas de liberacion controlada que contienen tiagabina. | |
YU20050411A (sh) | Komopzicije oksikodona sa kontrolisanim oslobadanjem |